Japan Approves Gilead’s Remdesivir to Treat Covid-19 Cases

(Bloomberg) -- Japan on Thursday approved the antiviral drug remdesivir for use against the novel coronavirus, three days after receiving an application from Gilead Sciences Inc., the company said ...